UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No.     )*

UNILEVER PLC

(Name of Issuer)

Ordinary Shares of the nominal amount of 3 1/9 pence each

(Title of Class of Securities)

G92087165

(CUSIP Number)

Paul David Read

1 Pemberton Row

London EC4A 3BG

United Kingdom

+44 (0) 20 7042 9881

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

with copy to:

Thomas B. Shropshire, Jr.

Linklaters LLP

One Silk Street

London EC2Y 8HQ

United Kingdom

+44 (0) 20 7456 3223

31 December 2014

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ¨

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Item 1. Security and Issuer.

This beneficial ownership statement on Schedule 13D (this “Schedule 13D”) relates to the ordinary shares, nominal value of 3 1/9 pence each (the “Ordinary Shares”), of Unilever PLC (the “Issuer”), whose principal executive offices are located at Unilever House, 100 Victoria Embankment, London EC4Y 0DY, United Kingdom.

Item 2. Identity and Background.

This Schedule 13D is being filed by The Leverhulme Trust, a charitable incorporated organisation organised under the laws of England and Wales (“The Leverhulme Trust CIO”), and The Leverhulme Trade Charities Trust, a charitable incorporated organisation organised under the laws of England and Wales (“The Leverhulme Trade Charities Trust CIO”, together with The Leverhulme Trust CIO, the “Reporting Persons”).

The Leverhulme Trust CIO is a charitable organisation that provides grants and scholarships for research and education. The Leverhulme Trade Charities Trust CIO makes grants to charitable organisations and other institutions that are connected with chemists, grocers and commercial travellers and awards bursaries for university study for people in need, and for those who have a connection with the three beneficiary trade groups.

The Reporting Persons were originally established in the form of a single trust in 1925 by the will of William Hesketh Lever (“Lord Leverhulme”), the founder of Lever Brothers, the predecessor entity of the Issuer. In his will, Lord Leverhulme left a share of holdings in Lever Brothers to the trust, which became a shareholding in the Issuer upon Lever Brothers merger with Margarine Unie in 1929. In 1983, the High Court of Justice of England and Wales approved a declaration of Charitable Trust, which gave the trust’s two charitable purposes (as set out above) each an existence as an independent charitable trust, including their own shareholdings in the Issuer. The Leverhulme Trust (“The Leverhulme Trust (charitable trust)”) was solely concerned with research and education while the eligible trade charities became the focus of The Leverhulme Trade Charities Trust (“The Leverhulme Trade Charities Trust (charitable trust)”).

With effect from midnight on 31 December 2014, each of The Leverhulme Trust (charitable trust) and The Leverhulme Trade Charities Trust (charitable trust) changed its legal status and the assets of each were transferred to charitable incorporated organisations of the same respective names.

The principal executive office of The Leverhulme Trust CIO is located at 1 Pemberton Row, London EC4A 3BG, United Kingdom. The principal executive office of The Leverhulme Trade Charities Trust CIO is located at 1 Pemberton Row, London EC4A 3BG, United Kingdom.

The Reporting Persons have common charity trustees (“directors”). Niall William Arthur FitzGerald, Ashok Sekhar Ganguly, Patrick Jean-Pierre Cescau, Paulus Geradus Josephus Maria Polman, Sir James Iain Walker Anderson, Alan Clive Butler, Rudolph Harold Peter Markham and Stephen Geoffrey Williams are directors of both Reporting Persons. The name, residence or business address, present principal occupation or employment, including name, principal business and address of any corporation or other organisation in which such employment is conducted, and citizenship of each of the executive officers and directors of the Reporting Persons are set forth in Schedule A hereto and are incorporated by reference herein. Messrs. FitzGerald, Ganguly, Cescau, Polman and Anderson were the trustees of The Leverhulme Trust (charitable trust) and The Leverhulme Trade Charities Trust (charitable trust).

During the last five years, neither the Reporting Persons nor, to the best of their knowledge, any of the persons listed in Schedule A hereto has been: (i) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

The Reporting Persons have entered into a Joint Filing Agreement, dated 12 January 2015, a copy of which is filed with this Schedule 13D as Exhibit 99.1, pursuant to which they have agreed to file this Schedule 13D jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act 1934, as amended (the “Exchange Act”).

Item 3. Source and Amount of Funds or Other Consideration.

As described in Item 2 above, effective midnight on 31 December 2014, each of The Leverhulme Trust (charitable trust) and The Leverhulme Trade Charities Trust (charitable trust) changed its legal status. On such date, the trustees of The Leverhulme Trust (charitable trust) transferred 68,531,182 Ordinary Shares to The Leverhulme Trust CIO pursuant to a transfer agreement, a copy of which is attached as Exhibit 99.2 to this Schedule 13D, and the trustees of The Leverhulme Trade Charities Trust (charitable trust) transferred 2,035,582 Ordinary Shares to The Leverhulme Trade Charities Trust CIO pursuant to a separate transfer agreement, a copy of which is attached as Exhibit 99.3 to this Schedule 13D (together, the “Transfer Agreements”). No monies were exchanged by either The Leverhulme Trust CIO or The Leverhulme Trade Charities Trust CIO.

Transfer Agreements

Under the Transfer Agreements, the trustees of each of The Leverhulme Trust (charitable trust) and The Leverhulme Trade Charities Trust (charitable trust) agreed to transfer all property and assets, including each trust’s respective shareholding in the Issuer, used in connection with the activities each trust carried out in accordance with its respective charitable objects (the “charitable undertakings”) to The Leverhulme Trust CIO and The Leverhulme Trade Charities Trust CIO, respectively, to hold for each Reporting Person’s respective charitable purpose. In consideration for the transfer, the Reporting Persons assumed all debts, liabilities and obligations of any nature relating to the respective charitable undertaking of their predecessor trust with a view to carrying on the respective charitable undertaking as a going concern.

The transfer became effective as of midnight on 31 December 2014. The Reporting Persons agreed to indemnify and keep indemnified each trustee against any loss, liability and cost which such trustee incurred and which was not discharged before the effective date in connection with (i) the ownership and proper operation of the charitable undertaking and the assets of The Leverhulme Trust (charitable trust) and The Leverhulme Trade Charities Trust (charitable trust), respectively, or (ii) as a result of either Reporting Persons’ failure to pay, satisfy or perform the assumed liabilities under the respective Transfer Agreement, including any losses, liabilities or costs incurred as a result of defending or settling a claim alleging such a liability.

The preceding description of the Transfer Agreements contained herein is qualified in its entirety by reference to Exhibits 99.2 and 99.3, which are incorporated herein by reference.

Item 4. Purpose of Transaction.

The information set forth in Items 3 and 6 is hereby incorporated by reference in this Item 4.

The Reporting Persons acquired the Ordinary Shares reported on this Schedule 13D for investment purposes.

Each of the persons listed in Schedule A has acquired the Ordinary Shares disclosed in Schedule B as beneficially owned by him/her for investment purposes or, in the case of Paulus Geradus Josephus Maria Polman, Gordon Marshall and Paul David Read, as compensation for, and in connection with, serving as Chief Executive Officer of the Issuer, Director of the Reporting Persons, and

Director of Finance of the Reporting Persons, respectively. Mr. Polman is a director of the Reporting Persons, the Chief Executive Officer of the Issuer and a member of the Issuer’s Board of Directors. In these capacities, Mr. Polman takes and will continue to take an active role in the Issuer’s management and strategic direction. By virtue of his positions with the Issuer, Mr. Polman is an affiliate as defined in the Securities Act of 1933, as amended. In his role with the Issuer, he develops plans and proposes changes relating to the management, composition of the Board of Directors, policies, operations, capital structure and business of the Issuer.

The Reporting Persons and the persons listed in Schedule A may, from time to time, in the ordinary course of business, depending on the factors discussed herein, their roles as directors and executives of the Reporting Persons, and the objectives of the Reporting Persons, seek to purchase, acquire, retain, sell, assign, transfer, endorse, pledge, hypothecate and otherwise dispose of all or a portion of the Ordinary Shares in the open market or in privately negotiated transactions. Any actions the Reporting Persons and the persons listed in Schedule A might undertake will be dependent upon the Reporting Persons’ and the persons listed in Schedule A’s, respectively, review of numerous factors, including, among other things, the price levels of the Ordinary Shares; general market and economic conditions; ongoing evaluation of the Issuer’s business, financial condition, operations and prospects; the relative attractiveness of alternative business and investment opportunities; the objectives of the Reporting Persons; and other future developments.

Except as otherwise set forth herein, neither the Reporting Persons nor, to the best of their knowledge, any of the persons listed in Schedule A hereto has any present plan or proposal that would relate to, or result in, any of the matters set forth in paragraphs (a) through (j) of Item 4 of Schedule 13D.

Notwithstanding the foregoing, the Reporting Persons and the persons listed in Schedule A hereto reserve their rights in full to change their intentions with respect to any and all matters referred to in Item 4 of Schedule 13D as they deem appropriate.

Item 5. Interest in Securities of the Issuer.

(a)-(b)

The responses of the Reporting Persons to Rows (11) through (13) of the cover pages of this Schedule 13D and the information set forth in Item 3 are hereby incorporated by reference in this Item 5.

The Ordinary Shares deemed beneficially owned by each of the Reporting Persons with respect to which such person (i) has sole voting power, (ii) shares voting power, (iii) has sole dispositive power and (iv) shares dispositive power are listed in the responses to Items 7, 8, 9 and 10, respectively, of the cover page of this Schedule 13D relating to such person and are incorporated by reference herein.

In addition, by virtue of the relationship among the Reporting Persons, the Reporting Persons may be deemed a “group” under the Exchange Act. The group constituted by the Reporting Persons beneficially owns 70,566,764 Ordinary Shares, which represents 5.5 per cent. of the Issuer’s outstanding share capital exclusive of shares held on behalf of the Issuer.

The aggregate number and percentage of Ordinary Shares beneficially owned by each of the persons listed in Schedule A and the Ordinary Shares deemed beneficially owned by each such person with respect to which such person (i) has sole voting power, (ii) shares voting power, (iii) has sole dispositive power and (iv) shares dispositive power are set forth in Schedule B hereto and are incorporated by reference herein.

Except as disclosed in this Schedule 13D, neither the Reporting Persons nor, to the best of their knowledge, any of the persons listed in Schedule A hereto beneficially owns any Ordinary Shares or has the right to acquire any Ordinary Shares.

Except as disclosed in this Schedule 13D, neither the Reporting Persons nor, to the best of their knowledge, any of the persons listed in Schedule A hereto presently has the power to vote or to direct the vote or to dispose or direct the disposition of any of the Ordinary Shares which they may be deemed to beneficially own.

(c)

The information set forth in Item 3 and the transactions by the persons listed in Schedule A set out in Schedule B hereto are incorporated by reference herein. Except as disclosed in this Schedule 13D, neither the Reporting Persons nor, to the best of their knowledge, any of the persons listed in Schedule A hereto has effected any transaction in the Ordinary Shares during the past 60 days.

(d)

To the best knowledge of the Reporting Persons and the persons listed in Schedule A, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Ordinary Shares beneficially owned by the Reporting Persons and the persons listed in Schedule A, respectively.

(e)

Not applicable.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

The information set forth in Items 2, 3, 4 and 5 is hereby incorporated by reference in this Item 6.

As part of his compensation for acting as the Chief Executive Officer of the Issuer, Mr. Polman receives equity in the Issuer under certain equity compensation plans. Details of these plans are set out in Unilever’s annual reports on Form 20-F. These reports are filed with the U.S. Securities and Exchange Commission and are available on its website, www.sec.gov. As part of their compensation for acting as Director and Director of Finance for the Leverhulme Trust, Mr. Marshall and Mr. Read, respectively, receive equity in the Issuer under certain equity compensation plans.

Except as described above or elsewhere in this Schedule 13D, or incorporated by reference in this Schedule 13D, there are no contracts, arrangements, understandings or relationships (legal or otherwise) between the Reporting Persons or, to the best of their knowledge, any of the persons named in Schedule A hereto or between the Reporting Persons and any other person or, to the best of their knowledge, any person named in Schedule A hereto and any other person with respect to any securities of the Issuer, including, but not limited to, transfer or voting of any securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or losses, or the giving or withholding of proxies.

Item 7. Materials to be Filed as Exhibits.

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: 12 January 2015

SCHEDULE A

The following sets forth as to each of the directors and executive officers of The Leverhulme Trust CIO and The Leverhulme Trade Charities Trust CIO: his name, his business address, his present principal occupation or employment and the name, principal business and address of any corporation or other organisation in which such employment is conducted. Unless otherwise specified, the principal business address of each such individual is 1 Pemberton Row, London EC4A 3BG, United Kingdom.

The Leverhulme Trust CIO

Directors and Executive Officers

The Leverhulme Trade Charities Trust CIO

Directors and Executive Officers

SCHEDULE B

Beneficial Ownership of Ordinary Shares

The following table sets forth, as of the date of this Schedule 13D, the aggregate number and percentage of Ordinary Shares beneficially owned by each of the persons listed in Schedule A, as well as the number of Ordinary Shares as to which each person listed in Schedule A has the sole power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition of as of the date hereof:

Transactions in Ordinary Shares

The following table sets forth, as of the date of this Schedule 13D, information with regard to transactions in the Ordinary Shares that were effected during the past sixty days by Mr. Polman:

EXHIBIT INDEX

EXHIBIT 99.1

JOINT FILING AGREEMENT

The undersigned hereby agree that the Statement on Schedule 13D, dated 12 January 2015, with respect to the ordinary shares, nominal amount of 3 1/9 pence each, of Unilever PLC is, and any amendments thereto executed by each of us shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities and Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to the Schedule 13D and each such amendment. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the 12^th day of January 2015.

2

EXHIBIT 99.2

Confidential portions of

this exhibit have

been omitted and filed

separately with the

Securities and Exchange

Commission

TRANSFER AGREEMENT

31 DECEMBER 2014

BETWEEN

THE TRUSTEES OF THE LEVERHULME TRUST

(charitable trust)

and

THE LEVERHULME TRUST

(charitable incorporated organisation)

A12601/14/2032876

CONTENTS

THIS DEED is made 31 December 2014

BETWEEN

WHEREAS:

IT IS AGREED as follows:

“AEL” means Associated Enterprises Limited;

“Assets” means the several assets to be transferred by the Trustees to the CIO under this agreement and described in clause 2.1;

“Assumed Liabilities” means all debts, liabilities and obligations of any nature of the Trustees relating to the Charitable Undertaking or the Assets, whether actual or contingent, which are due or outstanding on or have accrued at the Effective Time, including the Creditors, but not any liability in relation to which the Trustees would not be entitled to an indemnity under the general law had they continued as the trustees of the Trust;

“Charitable Undertaking” means the activities of the Trust as carried out in accordance with the charitable objects of the Trust set out in clause 4 of the Trust Deed (as replaced by the Scheme);

1

“Claims” means all rights and claims of the Trustees arising at any time (whether before or after the Effective Time) under any warranty, term, condition, guarantee or indemnity, whether express or implied, in favour of the Trustees in relation to any Asset;

“Completion” means completion of the transfer of the Charitable Undertaking and acquisition of the Assets in accordance with clause 5;

“Contracts” means all contracts and engagements (including contracts for services between the Trustees and their independent contractors but excluding contracts of service between the Trustees and their employees) entered into or orders made before the Effective Time by or on behalf of the Trustees with third parties in connection with the Charitable Undertaking which remain (in whole or in part) to be performed at the Effective Time including (but without limitation) all orders and contracts for the sale or purchase of goods or provision or supply of services or for the hire purchase, credit sale, leasing or license of goods or services, and including, in particular, those shortly described in Schedule 2;

“Creditors” means all financial obligations and accrued charges owing by the Trustees at the Effective Time;

“Debts” means (i) any debts or other sums due or payable to the Trustees in connection with the Charitable Undertaking at the Effective Time including, but not limited to, the benefit of any right to reclaim or be refunded tax, (ii) any debts or other sums which become due or payable to the Trustees after the Effective Time in connection with goods supplied or services performed in connection with the Charitable Undertaking prior to the Effective Time, (iii) any interest payable on those debts or other sums and (iv) the benefit of all securities, guarantees, indemnities and rights relating to those debts or other sums;

“Effective Time” means midnight on 31 December 2014;

“Employees” means those individuals employed jointly by the Outgoing Employer in respect of the Charitable Undertaking and named in Schedule 3;

“Employment Regulations” means the Transfer of Undertakings (Protection of Employment) Regulations 2006 (as amended);

“Encumbrances” means any mortgage, charge (fixed or floating), pledge, lien, hypothecation, guarantee, trust, right of set-off or other third party right or interest (legal or equitable) including any assignment by way of security, reservation of title or other security interest of any kind, however created or arising, or any other agreement or arrangement (including a sale and repurchase agreement) having similar effect;

“Equipment” means all the plant, machinery, spare parts, tools, equipment, tangible chattels, motor vehicles, furniture, fixtures and fittings (to the extent they are not included in the property demised by the Lease) owned and used by the Trustees in connection with the Charitable Undertaking; “Goodwill” means the goodwill of the Charitable Undertaking related to the exclusive right to carry on the Charitable Undertaking in succession to the Trustees;

“Intellectual Property” means all Intellectual Property Rights owned by the Trustees and used in connection with the Charitable Undertaking;

“Intellectual Property Rights” means trade marks, service marks, trade and business names, rights in designs, patents, copyright, database rights, moral rights and rights in know-how and other intellectual property rights in each case whether registered or unregistered and including applications for the grant of any of the foregoing and all rights or forms of protection having equivalent or similar effect to any of the foregoing which may subsist anywhere in the world;

2

“IT System” means all computer hardware (including network and telecommunications equipment) software (including associated preparatory materials, user manuals and other related documentation) and peripherals owned, used, leased or licenced by or in relation to the Charitable Undertaking.

“Investments” means the portfolio of investments referred to in Schedule 4.

“Lease” means a lease of premises known as 2^nd Floor Offices, 1/3 Pemberton Row, London EC4A 3EX and made between Co-Operative Insurance Society Limited (1) and Sir Michael Sidney Perry and others as trustees on behalf of The Leverhulme Trust (2) and dated 4 April 2012;

“New Employer” means the CIO and Unilever UK Central Resources Limited jointly;

“Outgoing Employer” means the Trustees and Unilever UK Central Resources Limited jointly;

“Trust Fund” has the meaning given to it by clause 2(b) of the Trust Deed; and

“UUKPF” means the Unilever UK Pension Fund.

3

4

5

6

IN WITNESS of which this deed has been executed and has been delivered on the date which appears first on page 1.

7

SCHEDULE 1

TRUSTEES

Dr Ashok Ganguly

Niall FitzGerald

Patrick Cescau

Paul Polman

Sir James Anderson

8

SCHEDULE 2

CONTRACTS

Including but not limited to:

9

SCHEDULE 3

EMPLOYEES

Cater, Jean Helen

Thorp, Nicola

Kerr, Bridget Philomena

Read, Paul David

Dillnutt, Matthew George

Sheppard, Bahia Mary

Mistry, Reena Hitan

Hughes, Cassandra

Heiner, Andreas Richard

White, Samuel David

Jaime, Maria Angeles

Grundy, Anna Marie

Marshall, Robert Gordon

Dupin, Gillian Naomi

10

SCHEDULE 4

INVESTMENTS

11

FOIA confidential treatment requested: [***] indicates that certain information contained herein has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to such omitted portions.

SIGNATURES

12

FOIA confidential treatment requested: [***] indicates that certain information contained herein has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to such omitted portions.

13

EXHIBIT 99.3

Confidential portions of

this exhibit have

been omitted and filed

separately with the

Securities and Exchange

Commission

TRANSFER AGREEMENT

31 DECEMBER 2014

BETWEEN

THE TRUSTEES OF THE LEVERHULME TRADE CHARITIES TRUST

(charitable trust)

and

THE LEVERHULME TRADE CHARITIES TRUST

(charitable incorporated organisation)

11289/2/2051055

CONTENTS

THIS DEED is made 31 December 2014

BETWEEN

WHEREAS:

IT IS AGREED as follows:

“Assets” means the several assets to be transferred by the Trustees to the CIO under this agreement and described in clause 2.1;

“Assumed Liabilities” means all debts, liabilities and obligations of any nature of the Trustees relating to the Charitable Undertaking or the Assets, whether actual or contingent, which are due or outstanding on or have accrued at the Effective Time, including the Creditors, but not any liability in relation to which the Trustees would not be entitled to an indemnity under the general law had they continued as the trustees of the Trust;

“Charitable Undertaking” means the activities of the Trust as carried out in accordance with the charitable objects of the Trust set out in clause 4 of the Trust Deed (as replaced by the Scheme);

1

“Claims” means all rights and claims of the Trustees arising at any time (whether before or after the Effective Time) under any warranty, term, condition, guarantee or indemnity, whether express or implied, in favour of the Trustees in relation to any Asset;

“Completion” means completion of the transfer of the Charitable Undertaking and acquisition of the Assets in accordance with clause 5;

“Contracts” means all contracts and engagements (including contracts for services between the Trustees and their independent contractors but excluding contracts of service between the Trustees and their employees) entered into or orders made before the Effective Time by or on behalf of the Trustees with third parties in connection with the Charitable Undertaking which remain (in whole or in part) to be performed at the Effective Time including (but without limitation) all orders and contracts for the sale or purchase of goods or provision or supply of services or for the hire purchase, credit sale, leasing or license of goods or services, and including, in particular, those shortly described in Schedule 2;

“Creditors” means all financial obligations and accrued charges owing by the Trustees at the Effective Time;

“Debts” means (i) any debts or other sums due or payable to the Trustees in connection with the Charitable Undertaking at the Effective Time including, but not limited to, the benefit of any right to reclaim or be refunded tax, (ii) any debts or other sums which become due or payable to the Trustees after the Effective Time in connection with goods supplied or services performed in connection with the Charitable Undertaking prior to the Effective Time, (iii) any interest payable on those debts or other sums and (iv) the benefit of all securities, guarantees, indemnities and rights relating to those debts or other sums;

“Effective Time” means midnight on 31 December 2014;

“Encumbrances” means any mortgage, charge (fixed or floating), pledge, lien, hypothecation, guarantee, trust, right of set-off or other third party right or interest (legal or equitable) including any assignment by way of security, reservation of title or other security interest of any kind, however created or arising, or any other agreement or arrangement (including a sale and repurchase agreement) having similar effect;

“Goodwill” means the goodwill of the Charitable Undertaking related to the exclusive right to carry on the Charitable Undertaking in succession to the Trustees;

“Intellectual Property” means all Intellectual Property Rights owned by the Trustees and used in connection with the Charitable Undertaking;

“Intellectual Property Rights” means trade marks, service marks, trade and business names, rights in designs, patents, copyright, database rights, moral rights and rights in know-how and other intellectual property rights in each case whether registered or unregistered and including applications for the grant of any of the foregoing and all rights or forms of protection having equivalent or similar effect to any of the foregoing which may subsist anywhere in the world;

“IT System” means all computer hardware (including network and telecommunications equipment) software (including associated preparatory materials, user manuals and other related documentation) and peripherals owned, used, leased or licenced by or in relation to the Charitable Undertaking.

“Investments” means the portfolio of investments referred to in Schedule 4.

“Trust Fund” has the meaning given to it by clause 2(b) of the Trust Deed;

2

3

4

5

IN WITNESS of which this deed has been executed and has been delivered on the date which appears first on page 1.

6

SCHEDULE 1

TRUSTEES

Dr Ashok Ganguly

Niall FitzGerald

Patrick Cescau

Paul Polman

Sir James Anderson

7

SCHEDULE 2

CONTRACTS

Including but not limited to:

8

SCHEDULE 3

INVESTMENTS

All of the assets held in the name of or on behalf of the Trustees including but not limited to the Shareholding in Unilever PLC of 2,035,582 Ordinary Shares of 3 1/9 pence.

9

FOIA confidential treatment requested: [***] indicates that certain information contained herein has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to such omitted portions.

SIGNATURES

10

FOIA confidential treatment requested: [***] indicates that certain information contained herein has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to such omitted portions.

11